Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The ...
In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The findings suggest that the treatment may work as an add-on therapy to standard ...
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
Secondary outcomes included performance on a gait speed test, Barthel Index (BI), NIH Stroke Scale score (NIHSS), Fluid-attenuated inversion recovery (FLAIR) MRI, resting state fMRI and ...